Modeling of valspodar (PSC 833) in elderly patients with acute myeloid leukemia (AML)

被引:0
|
作者
Uyl-de Groot, CA [1 ]
McDonnell, J [1 ]
Wait, S [1 ]
机构
[1] Erasmus Univ, IMTA, Rotterdam, Netherlands
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:225 / 225
页数:1
相关论文
共 50 条
  • [41] MODELING and Targeting ERG-INDUCED Acute MYELOID LEUKEMIA (AML)
    Smooha, Gil
    Birger, Yehudit
    Goldberg, Liat
    Jacob-Hirsch, Jasmine
    Amariglio, Ninette
    Rechavi, Gideon
    Levanon, Ditsa
    Groner, Yoram
    Taragan, Anat
    Kloog, Yoel
    Wen, Jeremy Q.
    Crispino, John
    Radmacher, Michael D.
    Marcucci, Guido
    Bloomfield, Clara D.
    Izraeli, Shai
    [J]. BLOOD, 2009, 114 (22) : 196 - 196
  • [42] INTENSIVE TREATMENT OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML)
    MULDER, NH
    DEVRIES, EGE
    HOUWEN, B
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 1980, 23 (04): : 179 - 179
  • [43] AngioCRIME in Acute Myeloid Leukemia (AML)
    Macintyre, Elizabeth
    [J]. HEMASPHERE, 2017, 1 (01):
  • [44] A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a Southwest Oncology Group study 9617
    Chauncey, TR
    Rankin, C
    Anderson, JE
    Chen, IM
    Kopecky, KJ
    Godwin, JE
    Kalaycio, ME
    Moore, DF
    Shurafa, MS
    Petersdorf, SH
    Kraut, EH
    Leith, CP
    Head, DR
    Luthardt, FW
    Willman, CL
    Appelbaum, FR
    [J]. LEUKEMIA RESEARCH, 2000, 24 (07) : 567 - 574
  • [45] Preventive antibiotics in pediatric patients with acute myeloid leukemia (AML)
    Nolt, Dawn
    Lindemulder, Susan
    Meyrowitz, Jeffrey
    Chang, Bill H.
    Malempati, Suman
    Thomas, Gregory
    Stork, Linda
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 (07) : 1149 - 1154
  • [46] VITAMIN C DEFICIENCY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
    Ottone, T.
    Faraoni, I.
    Fucci, G.
    Divona, M.
    De Bellis, E.
    Marchesi, F.
    Angelini, D. F.
    Palmieri, R.
    Gurnari, C.
    Giansanti, M.
    Nardozza, A. M.
    Montesano, F.
    Travaglini, S.
    Puzzangara, M. C.
    De Angelis, G.
    Cicconi, L.
    De Bardi, M.
    Battistini, L.
    Massoud, R.
    Venditti, A.
    Voso, M. T.
    [J]. HAEMATOLOGICA, 2021, 106 (10) : 96 - 97
  • [47] An early-phase study of azacitidine and lenalidomide for untreated elderly acute myeloid leukemia (AML) patients
    Pollyea, D. A.
    Kohrt, H. E.
    Rajwanshi, R.
    Gallegos, L.
    Berube, C.
    Coutre, S. E.
    Gotlib, J. R.
    Liedtke, M.
    Mitchell, B. S.
    Medeiros, B. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] ACUTE MYELOID LEUKEMIA (AML) IN ELDERLY PACIENTS. ANALYSIS OF 92 CASES
    Infante, M. S.
    Ballesteros, M.
    Gonzalez-Gascon, I.
    Font, P.
    Carretero, F.
    Rodriguez Macias, G.
    Encinas, C.
    Osorio, S.
    Perez Sanchez, I.
    Kwon, M.
    Gayoso, J.
    Escudero, A.
    Diez Martin, J.
    [J]. HAEMATOLOGICA, 2012, 97 : 509 - 509
  • [49] Outcome of Elderly Patients with Acute Myeloid Leukemia (AML) Post Hypomethylating Agent (HMA) Failure.
    Takahashi, Koichi
    Kantarjian, Hagop M.
    Ghanem, Hady
    Ravandi, Farhad
    Cortes, Jorge E.
    Kadia, Tapan M.
    O'Brien, Susan
    Pierce, Sherry A.
    Jain, Nitin
    Garcia-Manero, Guillermo
    Jabbour, Elias J.
    [J]. BLOOD, 2012, 120 (21)
  • [50] Oral chemotherapeutic agents in elderly acute myeloid leukemia (AML) patients, a study from a developing country
    Mukhopadhyay, S.
    Chitalkar, P.
    Gupta, P.
    Roy, U.
    Mukhopadhyay, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)